Promotion and PR

WASHINGTON - The FDA last week disclosed that it is working on a guidance document about "the dissemination of press releases by sponsors, or on their behalf, containing information concerning investigational drugs," and asked for public comments on guidance documents

Read the full 409 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE